Devonian Health Group Inc.
GSD.V
TSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 357.27% | 727.46% | 1,159.94% | 402.14% | 203.96% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 357.27% | 727.46% | 1,159.94% | 402.14% | 203.96% |
| Cost of Revenue | 444.86% | 823.04% | 1,356.48% | 364.32% | 181.22% |
| Gross Profit | 228.87% | 606.57% | 788.82% | 496.16% | 244.51% |
| SG&A Expenses | 97.51% | 77.31% | 12.30% | 109.49% | -15.44% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1.31% | 1.87% | 4.27% | 4.09% | 4.57% |
| Total Operating Expenses | 221.00% | 312.65% | 192.93% | 136.50% | 24.18% |
| Operating Income | 49.68% | 248.06% | 80.23% | -15.14% | 42.90% |
| Income Before Tax | 50.14% | 221.99% | 74.89% | -14.66% | 40.90% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 50.14% | 221.99% | 74.89% | -14.66% | 40.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 50.14% | 221.99% | 74.89% | -14.66% | 40.90% |
| EBIT | 49.68% | 248.06% | 80.23% | -15.14% | 42.90% |
| EBITDA | 56.25% | 307.87% | 86.67% | -17.02% | 47.27% |
| EPS Basic | 50.00% | 220.45% | 77.11% | -3.39% | 47.83% |
| Normalized Basic EPS | 52.17% | 222.22% | 76.92% | -2.70% | 46.51% |
| EPS Diluted | 51.35% | 220.45% | 77.11% | 0.00% | 46.38% |
| Normalized Diluted EPS | 52.17% | 222.22% | 76.92% | -2.70% | 46.51% |
| Average Basic Shares Outstanding | 1.55% | 0.57% | 11.48% | 10.62% | 11.25% |
| Average Diluted Shares Outstanding | 1.55% | 0.57% | 11.48% | 10.62% | 11.25% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
